May 23, 2025
Advancing Molecular Simulation for Faster Drug Development
Qubit Pharmaceuticals, in collaboration with Sorbonne University, has unveiled FeNNix-Bio1, the world’s most powerful quantum AI model. This groundbreaking technology enables ultra-precise molecular simulations, revolutionizing the drug discovery process by significantly speeding up the design and testing of new therapies.
Cutting Time and Cost in Drug R&D
FeNNix-Bio1 leverages quantum AI to dramatically reduce the time and expense traditionally associated with chemical synthesis. By generating thousands of novel molecules quickly and accurately, it allows researchers to focus on the most promising candidates, streamlining drug development.
Harnessing Leading Computational Power
Built on advanced quantum computing infrastructure and trained on extensive molecular data, FeNNix-Bio1 understands fundamental chemical and physical principles. This capability enables it to reconstruct complex biomolecular structures with exceptional precision.
Enabling Innovative Drug Design
The model simulates intricate molecular interactions, including chemical bonding and water-ion dynamics, paving the way for designing next-generation drugs such as covalent therapeutics.
Pioneering Pharmaceutical Innovation
Qubit Pharmaceuticals’ FeNNix-Bio1 represents a major leap in integrating quantum computing and AI to accelerate pharmaceutical R&D, reduce costs, and bring innovative treatments to patients faster.
By